 Lisa Spencer
Concepts (238)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Eosinophils | 31 | 2022 | 278 | 7.680 |
Why?
| | Hypersensitivity | 3 | 2022 | 252 | 1.590 |
Why?
| | Intestine, Small | 2 | 2021 | 122 | 1.190 |
Why?
| | Eosinophilia | 5 | 2021 | 186 | 1.180 |
Why?
| | Enteritis | 4 | 2022 | 82 | 1.170 |
Why?
| | Antigen Presentation | 2 | 2018 | 188 | 1.050 |
Why?
| | Gastritis | 3 | 2021 | 84 | 0.990 |
Why?
| | Eosinophilic Esophagitis | 3 | 2022 | 296 | 0.870 |
Why?
| | Duodenitis | 1 | 2022 | 7 | 0.830 |
Why?
| | Allergens | 3 | 2022 | 413 | 0.810 |
Why?
| | CD11 Antigens | 1 | 2022 | 30 | 0.790 |
Why?
| | Receptors, Notch | 2 | 2015 | 84 | 0.770 |
Why?
| | Intestines | 2 | 2021 | 326 | 0.730 |
Why?
| | Cytokines | 7 | 2017 | 1840 | 0.720 |
Why?
| | Mucous Membrane | 1 | 2020 | 108 | 0.670 |
Why?
| | Immunity, Innate | 5 | 2017 | 720 | 0.640 |
Why?
| | Flow Cytometry | 5 | 2021 | 1083 | 0.640 |
Why?
| | Integrins | 1 | 2019 | 79 | 0.640 |
Why?
| | Cell Degranulation | 7 | 2017 | 39 | 0.630 |
Why?
| | Th2 Cells | 2 | 2010 | 154 | 0.610 |
Why?
| | Intestinal Mucosa | 2 | 2021 | 532 | 0.550 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2015 | 140 | 0.550 |
Why?
| | Environmental Exposure | 1 | 2020 | 372 | 0.550 |
Why?
| | Receptors, IgG | 1 | 2016 | 67 | 0.540 |
Why?
| | Adrenal Cortex Hormones | 1 | 2019 | 497 | 0.520 |
Why?
| | Immunity, Humoral | 1 | 2016 | 112 | 0.510 |
Why?
| | Transendothelial and Transepithelial Migration | 1 | 2015 | 29 | 0.490 |
Why?
| | Immunoglobulin E | 1 | 2016 | 314 | 0.490 |
Why?
| | Diet Therapy | 1 | 2015 | 36 | 0.480 |
Why?
| | Biomarkers | 3 | 2022 | 3408 | 0.480 |
Why?
| | Diet, Reducing | 1 | 2015 | 76 | 0.470 |
Why?
| | Extracellular Traps | 3 | 2019 | 40 | 0.440 |
Why?
| | Secretory Vesicles | 5 | 2016 | 24 | 0.440 |
Why?
| | Pregnancy Outcome | 1 | 2015 | 337 | 0.410 |
Why?
| | Postpartum Period | 1 | 2015 | 278 | 0.400 |
Why?
| | Organ Specificity | 3 | 2020 | 268 | 0.390 |
Why?
| | Interleukin-4 | 3 | 2008 | 206 | 0.380 |
Why?
| | Phenotype | 2 | 2022 | 2796 | 0.380 |
Why?
| | Chemokine CCL11 | 6 | 2016 | 22 | 0.360 |
Why?
| | Mice | 9 | 2022 | 14860 | 0.340 |
Why?
| | Animals | 16 | 2022 | 31694 | 0.340 |
Why?
| | Inflammation | 5 | 2022 | 2477 | 0.330 |
Why?
| | Signal Transduction | 5 | 2017 | 4509 | 0.320 |
Why?
| | Cytoplasmic Granules | 5 | 2017 | 82 | 0.320 |
Why?
| | Autocrine Communication | 1 | 2009 | 42 | 0.320 |
Why?
| | Galectins | 2 | 2019 | 22 | 0.320 |
Why?
| | Immunophenotyping | 3 | 2020 | 274 | 0.310 |
Why?
| | Asthma | 1 | 2021 | 2029 | 0.300 |
Why?
| | Leukocytes | 2 | 2021 | 276 | 0.300 |
Why?
| | Th1 Cells | 1 | 2008 | 123 | 0.300 |
Why?
| | Cell Differentiation | 3 | 2015 | 1700 | 0.280 |
Why?
| | Ligands | 1 | 2009 | 561 | 0.280 |
Why?
| | Receptors, Cytokine | 1 | 2006 | 33 | 0.260 |
Why?
| | Homeostasis | 2 | 2021 | 573 | 0.250 |
Why?
| | Humans | 33 | 2022 | 114623 | 0.230 |
Why?
| | Mice, Transgenic | 4 | 2018 | 1947 | 0.230 |
Why?
| | Cells, Cultured | 7 | 2016 | 3881 | 0.220 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 797 | 0.200 |
Why?
| | Crystallization | 2 | 2019 | 136 | 0.200 |
Why?
| | CD11c Antigen | 1 | 2022 | 38 | 0.200 |
Why?
| | Leukocyte Count | 1 | 2021 | 293 | 0.180 |
Why?
| | Tetraspanin 30 | 3 | 2016 | 9 | 0.170 |
Why?
| | Cell Separation | 1 | 2021 | 291 | 0.170 |
Why?
| | Mice, Inbred BALB C | 4 | 2016 | 1143 | 0.170 |
Why?
| | Cell Death | 2 | 2018 | 322 | 0.160 |
Why?
| | Pre-Exposure Prophylaxis | 1 | 2021 | 179 | 0.160 |
Why?
| | Immunoglobulin G | 1 | 2022 | 770 | 0.150 |
Why?
| | Disease Susceptibility | 1 | 2020 | 316 | 0.150 |
Why?
| | Exocytosis | 2 | 2016 | 89 | 0.150 |
Why?
| | Intraepithelial Lymphocytes | 1 | 2018 | 12 | 0.150 |
Why?
| | Antigen-Presenting Cells | 1 | 2018 | 150 | 0.140 |
Why?
| | Rare Diseases | 1 | 2018 | 89 | 0.140 |
Why?
| | Allergy and Immunology | 1 | 2018 | 51 | 0.140 |
Why?
| | Fluorescent Antibody Technique | 1 | 2018 | 397 | 0.140 |
Why?
| | In Vitro Techniques | 3 | 2009 | 1016 | 0.140 |
Why?
| | Eosinophil Granule Proteins | 2 | 2007 | 20 | 0.140 |
Why?
| | Advisory Committees | 1 | 2018 | 208 | 0.140 |
Why?
| | Ovalbumin | 1 | 2016 | 161 | 0.130 |
Why?
| | Health Services Needs and Demand | 1 | 2018 | 243 | 0.130 |
Why?
| | Antigens | 2 | 2016 | 318 | 0.130 |
Why?
| | Gastroenterology | 1 | 2018 | 159 | 0.130 |
Why?
| | Microscopy, Electron, Transmission | 6 | 2015 | 135 | 0.130 |
Why?
| | Adaptive Immunity | 1 | 2016 | 155 | 0.120 |
Why?
| | Decision Support Systems, Clinical | 1 | 2017 | 176 | 0.120 |
Why?
| | Anti-HIV Agents | 1 | 2021 | 666 | 0.120 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2019 | 663 | 0.120 |
Why?
| | Receptor, Notch1 | 1 | 2015 | 59 | 0.120 |
Why?
| | Respiratory Hypersensitivity | 1 | 2015 | 60 | 0.120 |
Why?
| | Models, Animal | 1 | 2016 | 344 | 0.120 |
Why?
| | Eosinophil Major Basic Protein | 3 | 2009 | 6 | 0.120 |
Why?
| | Gene Expression Regulation | 2 | 2017 | 2319 | 0.120 |
Why?
| | Disease Models, Animal | 3 | 2020 | 3531 | 0.120 |
Why?
| | Amyloid Precursor Protein Secretases | 1 | 2015 | 72 | 0.120 |
Why?
| | Adoptive Transfer | 1 | 2015 | 195 | 0.120 |
Why?
| | Inflammation Mediators | 1 | 2017 | 477 | 0.120 |
Why?
| | Machine Learning | 1 | 2017 | 316 | 0.120 |
Why?
| | Decision Support Techniques | 1 | 2017 | 355 | 0.110 |
Why?
| | MAP Kinase Signaling System | 1 | 2015 | 276 | 0.110 |
Why?
| | Mice, Knockout | 2 | 2016 | 2565 | 0.110 |
Why?
| | Microscopy, Immunoelectron | 3 | 2009 | 43 | 0.100 |
Why?
| | Life Style | 1 | 2015 | 430 | 0.100 |
Why?
| | Protein Transport | 3 | 2016 | 395 | 0.100 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2013 | 195 | 0.100 |
Why?
| | Ribonucleases | 1 | 2012 | 52 | 0.100 |
Why?
| | Detergents | 1 | 2011 | 41 | 0.100 |
Why?
| | Chemokines, CC | 3 | 2006 | 28 | 0.090 |
Why?
| | Mice, Inbred C57BL | 3 | 2016 | 4689 | 0.090 |
Why?
| | Cytoplasm | 2 | 2016 | 255 | 0.090 |
Why?
| | Algorithms | 1 | 2017 | 1466 | 0.090 |
Why?
| | Body Weight | 1 | 2015 | 868 | 0.090 |
Why?
| | RNA, Messenger | 1 | 2017 | 2552 | 0.090 |
Why?
| | Pregnancy Complications | 1 | 2015 | 429 | 0.090 |
Why?
| | Health | 1 | 2010 | 74 | 0.090 |
Why?
| | Gene Expression | 1 | 2015 | 1421 | 0.090 |
Why?
| | Helminths | 1 | 2010 | 7 | 0.090 |
Why?
| | Helminthiasis | 1 | 2010 | 10 | 0.090 |
Why?
| | Disease | 1 | 2010 | 85 | 0.090 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2011 | 352 | 0.080 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2015 | 1214 | 0.080 |
Why?
| | Receptors, Immunologic | 1 | 2010 | 201 | 0.080 |
Why?
| | Centrifugation, Density Gradient | 1 | 2009 | 40 | 0.080 |
Why?
| | Cell Fractionation | 1 | 2009 | 51 | 0.080 |
Why?
| | Jagged-2 Protein | 1 | 2009 | 1 | 0.080 |
Why?
| | Soluble N-Ethylmaleimide-Sensitive Factor Attachment Proteins | 1 | 2009 | 4 | 0.080 |
Why?
| | Serrate-Jagged Proteins | 1 | 2009 | 27 | 0.080 |
Why?
| | Endopeptidases | 1 | 2009 | 71 | 0.080 |
Why?
| | Incidence | 1 | 2015 | 2311 | 0.080 |
Why?
| | Receptors, Chemokine | 2 | 2006 | 44 | 0.080 |
Why?
| | Female | 5 | 2021 | 59466 | 0.080 |
Why?
| | DNA-Binding Proteins | 1 | 2015 | 1314 | 0.080 |
Why?
| | Interferon-gamma | 2 | 2008 | 719 | 0.080 |
Why?
| | Organelles | 1 | 2008 | 51 | 0.080 |
Why?
| | Peptide Hydrolases | 1 | 2009 | 104 | 0.080 |
Why?
| | Immunity, Cellular | 1 | 2010 | 248 | 0.070 |
Why?
| | Interleukin-13 | 1 | 2008 | 122 | 0.070 |
Why?
| | Lung | 1 | 2020 | 3558 | 0.070 |
Why?
| | Transcription Factors | 1 | 2015 | 1528 | 0.070 |
Why?
| | Calcium-Binding Proteins | 1 | 2009 | 206 | 0.070 |
Why?
| | HIV Infections | 1 | 2021 | 2469 | 0.070 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2009 | 351 | 0.070 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2009 | 386 | 0.070 |
Why?
| | Receptors, Interleukin-4 | 1 | 2006 | 15 | 0.070 |
Why?
| | Receptors, CCR3 | 1 | 2006 | 8 | 0.070 |
Why?
| | DNA | 1 | 2013 | 1352 | 0.070 |
Why?
| | Retrospective Studies | 1 | 2022 | 12542 | 0.070 |
Why?
| | Receptors, Interleukin-6 | 1 | 2006 | 34 | 0.070 |
Why?
| | Child | 2 | 2022 | 18404 | 0.060 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2008 | 339 | 0.060 |
Why?
| | Cell Survival | 1 | 2009 | 1020 | 0.060 |
Why?
| | Enzyme Inhibitors | 1 | 2009 | 750 | 0.060 |
Why?
| | Intracellular Membranes | 1 | 2005 | 73 | 0.060 |
Why?
| | Avidin | 1 | 2005 | 2 | 0.060 |
Why?
| | Sepharose | 1 | 2005 | 31 | 0.060 |
Why?
| | Gels | 1 | 2005 | 72 | 0.060 |
Why?
| | Exercise | 1 | 2015 | 1644 | 0.060 |
Why?
| | Staining and Labeling | 1 | 2005 | 134 | 0.060 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2008 | 1139 | 0.050 |
Why?
| | Pregnancy | 1 | 2015 | 5517 | 0.050 |
Why?
| | Membrane Proteins | 1 | 2009 | 1018 | 0.050 |
Why?
| | Antibodies | 1 | 2005 | 371 | 0.050 |
Why?
| | Obesity | 1 | 2015 | 2507 | 0.050 |
Why?
| | Brugia pahangi | 1 | 2002 | 1 | 0.050 |
Why?
| | Brugia malayi | 1 | 2002 | 3 | 0.050 |
Why?
| | Filariasis | 1 | 2002 | 4 | 0.050 |
Why?
| | Peritoneal Cavity | 1 | 2002 | 23 | 0.050 |
Why?
| | Cell Membrane | 2 | 2018 | 680 | 0.050 |
Why?
| | Langerhans Cells | 1 | 2001 | 11 | 0.050 |
Why?
| | Dermis | 1 | 2001 | 30 | 0.050 |
Why?
| | Lipopolysaccharide Receptors | 1 | 2001 | 81 | 0.050 |
Why?
| | Biological Transport | 2 | 2016 | 373 | 0.050 |
Why?
| | Protein Binding | 1 | 2006 | 1889 | 0.040 |
Why?
| | Emtricitabine | 1 | 2021 | 147 | 0.040 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2018 | 106 | 0.040 |
Why?
| | Immunohistochemistry | 2 | 2017 | 1629 | 0.040 |
Why?
| | Brefeldin A | 2 | 2008 | 14 | 0.040 |
Why?
| | Platelet Membrane Glycoproteins | 2 | 2009 | 39 | 0.040 |
Why?
| | Skin | 1 | 2001 | 655 | 0.040 |
Why?
| | Single-Blind Method | 1 | 2017 | 258 | 0.040 |
Why?
| | Factor Analysis, Statistical | 1 | 2017 | 257 | 0.030 |
Why?
| | Genetic Markers | 1 | 2017 | 320 | 0.030 |
Why?
| | Regulatory Factor X Transcription Factors | 1 | 2015 | 9 | 0.030 |
Why?
| | Health Personnel | 1 | 2021 | 574 | 0.030 |
Why?
| | X-Box Binding Protein 1 | 1 | 2015 | 7 | 0.030 |
Why?
| | Granulocyte Precursor Cells | 1 | 2015 | 7 | 0.030 |
Why?
| | Endoribonucleases | 1 | 2015 | 62 | 0.030 |
Why?
| | Antigens, CD | 2 | 2009 | 442 | 0.030 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2015 | 91 | 0.030 |
Why?
| | Microscopy, Confocal | 1 | 2015 | 304 | 0.030 |
Why?
| | United States | 2 | 2021 | 12176 | 0.030 |
Why?
| | Adult | 1 | 2015 | 30528 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2017 | 1691 | 0.030 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 923 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2015 | 591 | 0.030 |
Why?
| | Extracellular Space | 1 | 2013 | 116 | 0.030 |
Why?
| | Cell-Free System | 1 | 2012 | 47 | 0.020 |
Why?
| | Membranes, Artificial | 1 | 2011 | 65 | 0.020 |
Why?
| | Registries | 1 | 2017 | 1767 | 0.020 |
Why?
| | Hypereosinophilic Syndrome | 1 | 2009 | 9 | 0.020 |
Why?
| | Biological Transport, Active | 1 | 2009 | 71 | 0.020 |
Why?
| | Triiodobenzoic Acids | 1 | 2009 | 11 | 0.020 |
Why?
| | Subcellular Fractions | 1 | 2009 | 78 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2015 | 1518 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2013 | 1842 | 0.020 |
Why?
| | Proteoglycans | 1 | 2009 | 107 | 0.020 |
Why?
| | Cell Compartmentation | 1 | 2007 | 51 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2009 | 396 | 0.020 |
Why?
| | Blood Proteins | 1 | 2009 | 231 | 0.020 |
Why?
| | Microscopy, Electron | 1 | 2007 | 410 | 0.020 |
Why?
| | Chemokines | 1 | 2007 | 216 | 0.020 |
Why?
| | Blotting, Western | 1 | 2008 | 1147 | 0.020 |
Why?
| | Chemotactic Factors, Eosinophil | 1 | 2005 | 6 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2009 | 1230 | 0.020 |
Why?
| | Forecasting | 1 | 2007 | 330 | 0.020 |
Why?
| | Chemokine CCL5 | 1 | 2005 | 45 | 0.020 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2011 | 959 | 0.020 |
Why?
| | Protein Synthesis Inhibitors | 1 | 2005 | 42 | 0.020 |
Why?
| | Platelet Activating Factor | 1 | 2005 | 90 | 0.020 |
Why?
| | Infant | 1 | 2017 | 7959 | 0.010 |
Why?
| | Child, Preschool | 1 | 2017 | 9108 | 0.010 |
Why?
| | Molting | 1 | 2002 | 6 | 0.010 |
Why?
| | Immunocompetence | 1 | 2002 | 40 | 0.010 |
Why?
| | Receptors, CCR6 | 1 | 2001 | 3 | 0.010 |
Why?
| | Chemokine CCL20 | 1 | 2001 | 4 | 0.010 |
Why?
| | Macrophage Inflammatory Proteins | 1 | 2001 | 12 | 0.010 |
Why?
| | Imaging, Three-Dimensional | 1 | 2005 | 510 | 0.010 |
Why?
| | Granuloma | 1 | 2002 | 83 | 0.010 |
Why?
| | Mice, SCID | 1 | 2002 | 314 | 0.010 |
Why?
| | Chemotaxis | 1 | 2001 | 130 | 0.010 |
Why?
| | Endocytosis | 1 | 2001 | 148 | 0.010 |
Why?
| | Models, Biological | 1 | 2007 | 1620 | 0.010 |
Why?
| | Lymphocytes | 1 | 2002 | 330 | 0.010 |
Why?
| | Cell Division | 1 | 2001 | 758 | 0.010 |
Why?
| | Adolescent | 1 | 2017 | 17831 | 0.010 |
Why?
| | Kinetics | 1 | 2002 | 1551 | 0.010 |
Why?
| | Lymphocyte Activation | 1 | 2001 | 1037 | 0.010 |
Why?
| | Stem Cells | 1 | 2001 | 545 | 0.010 |
Why?
| | Male | 2 | 2017 | 55554 | 0.010 |
Why?
| | Macrophages | 1 | 2002 | 1261 | 0.010 |
Why?
|
|
Spencer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|